OTHER sector's biggest single-day movers show no identifiable fundamental catalyst
VIRAT, QUADFUTURE, SHANTIGEAR, NDL and Allcargo Logistics all posted roughly 15-20% single-day gains in the OTHER sector's top-movers list. Checking the largest name, Allcargo (+9-16% depending on source, on heavy volume), a dedicated writeup on the move could not identify a company-specific catalyst, pointing instead to technical/momentum factors -- consistent with the near-identical gains across the other four names looking more like small-cap speculative churn than a genuine sector catalyst.
Small and mid-cap bank Q1 FY27 results keep confirming the sector's broad-based recovery thesis, though Q2 data still isn't in Banks
Canara Bank, PNB, Karur Vysya and Karnataka Bank all posted Q1 FY27 results extending the pattern the open bank-smallcap-q1fy27-recovery-breadth claim describes: Canara's advances rose 17.97% YoY with NII crossing Rs 10,000cr for the first time; PNB's net profit more than tripled YoY with gross NPA improving to 2.78%; Karur Vysya's profit rose 45% YoY on 0.74% GNPA; and Karnataka Bank's NIM improved to 3.20% from 2.82% a year earlier. Tamilnad Mercantile Bank set ambitious FY27 targets on top of a strong recent run. None of this yet tests the claim's real falsifier, which needs Q2 FY27 results not due until September/October.
Infosys confirms a further FY27 guidance cut, leaving the sector-wide 'no large-cap has raised guidance' pattern intact Information Technology
Infosys's July 2026 update trimmed the top end of its FY27 constant-currency revenue guidance to 1.5-3.0%, down from 1.5-3.5% -- a genuine cut, not just a maintain, and the clearest confirmation yet of the open it-guidance-caution-fy27 claim. Pre-earnings brokerage commentary had flagged a similar risk at HCLTech (a possible ~100bps trim to the upper end of services growth guidance), but no confirmed post-Q1 guidance action from HCLTech itself turned up this session -- so the claim's bar (two or more of INFY/HCLTECH/TCS/LTM raising guidance) remains unmet in either direction.
Varun Beverages guides over 10% 2026 volume growth and closes a $32M Kenyan dairy/juice acquisition FMCG
Management guided volume growth above 10% for 2026 (with room for mid-teens growth in favorable weather) and a 26% EBITDA margin target. VBL's Kenyan subsidiary completed the $32M acquisition of DFIL Kenya (dairy beverages, juices, packaged water) effective August 1, 2026, extending its diversification beyond core CSD/water outside India. Q2 CY26 consolidated net profit rose 15.1% YoY to Rs 1,525.4 crore on H1 CY26 revenue up 19.4% YoY.
Max Healthcare's Kalinga Hospital dispute drags on as analysts split on the Q1 print and a Parliamentary panel floats hospital room-rate caps Healthcare & Hospitals
The NCLT oppression/mismanagement case at Max Healthcare's Kalinga Hospital subsidiary was adjourned again, at the petitioners' own request, to September 8, with no ruling on the merits after four months of procedural adjournments. Post-Q1 FY27 results, Motilal Oswal stayed bullish (target raised to Rs 1,410) while Anand Rathi trimmed its target to Rs 1,220, flagging a roughly 13.5% PAT miss on higher depreciation and finance costs from recent hospital commissioning and the Kalinga acquisition. Separately, a Parliamentary Standing Committee report recommending private hospital room rates be capped near three-star-hotel tariffs knocked hospital stocks, including Max Healthcare, about 3% -- a recommendation, not enacted policy, but one aimed squarely at the pricing power management has been leaning on to offset rising costs.